Better Cannabis Stock: Curaleaf vs. Trulieve fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Biggest past-year deals:
Subversive Capital s acquisition of Caliva and Left Coast Ventures ($425 million)
Curaleaf s acquisition of Emmac Life Sciences ($290 million)
Ayr Wellness acquisition of Liberty Health Sciences ($290 million)
Key individuals:
The firm declined to specify the lawyers who led its engagements for Curaleaf, Subversive, and Ayr Wellness.
About:
Stikeman Elliott is one of Canada s largest business law firms. The firm s lawyers worked with Curaleaf on two acquisitions, walked Ayr Wellness through its purchase of Liberty, and represented Canaccord Genuity, the financial advisor to the cannabis SPAC Subversive Capital Acquisition Corp., in its complex merger
From 2015 to 2018, Stikeman regularly worked with Aphria, with The Globe and Mail reporting that the two parted ways after a transaction that drew short-seller scrutiny. The firm declined to comment.
Some investors think growth stocks have lost their mojo.
However, all hope is not lost. Rates remain near historical lows, and there are now some great deals in the growth space today.
In this market, I think the opportunities are very concentrated right now. However, I’ve hand-picked three stocks I think have the potential to outperform this year and beyond.
So, let’s get to it.
Curaleaf Holdings
Cannabis stocks remain topics of discussion among growth investors right now. Indeed, hopes for U.S. legalization are spurring most of these discussions today.
In this environment, I think U.S.-based MSOs like